Search research articles
Contact Us
Filters
Showing results (11-20 of 56) with videos related to
Page
of 6
Sort By:
Plos One
|
March 4, 2014
Comparable autoantibody serum levels against amyloid- and inflammation-associated proteins in Parkinson's disease patients and controls
Walter Maetzler, Anja Apel, Markus Langkamp, et al.
NPJ Parkinson'S Disease
|
May 5, 2025
Differences in age-related distribution of CSF alpha-synuclein seeding and Alzheimer profiles between PD with and without GBA1 variants
Stefanie Lerche, Isabel Wurster, Benjamin Roeben, et al.
Neuro-Degenerative Diseases
|
October 21, 2016
Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia
Carlo Wilke, Frank Gillardon, Christian Deuschle, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 25, 2011
Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease
Stefan P Schmid, Erwin D Schleicher, Alexander Cegan, et al.
Molecular Pharmaceutics
|
April 17, 2023
Molecular Design of <sup>68</sup>Ga- and <sup>89</sup>Zr-Labeled Anticalin Radioligands for PET-Imaging of PSMA-Positive Tumors
Volker Morath, Corinna Brandt, Friedrich-Christian Deuschle, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 18, 2021
α-Synuclein in Plasma-Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease
Anne Stuendl, Tanja Kraus, Madhurima Chatterjee, et al.
European Journal of Neurology
|
July 1, 2024
Association of elevated cerebrospinal fluid levels of the longevity protein α-Klotho with a delayed onset of cognitive impairment in Parkinson's disease patients
Milan Zimmermann, Madeleine Fandrich, Meike Jakobi, et al.
Plos One
|
November 8, 2012
Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia
Walter Maetzler, Youyong Tian, Stephanie Maria Baur, et al.
Clinical Chemistry and Laboratory Medicine
|
June 29, 2019
Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches
Carlo Wilke, Fani Pujol-Calderón, Christian Barro, et al.
Plos One
|
March 12, 2016
Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors
Felix P Bernhard, Sebastian Heinzel, Gerhard Binder, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 56) with videos related to
Sort By:
Page
of 6
Plos One
|
March 4, 2014
Comparable autoantibody serum levels against amyloid- and inflammation-associated proteins in Parkinson's disease patients and controls
Walter Maetzler, Anja Apel, Markus Langkamp, et al.
NPJ Parkinson'S Disease
|
May 5, 2025
Differences in age-related distribution of CSF alpha-synuclein seeding and Alzheimer profiles between PD with and without GBA1 variants
Stefanie Lerche, Isabel Wurster, Benjamin Roeben, et al.
Neuro-Degenerative Diseases
|
October 21, 2016
Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia
Carlo Wilke, Frank Gillardon, Christian Deuschle, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 25, 2011
Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease
Stefan P Schmid, Erwin D Schleicher, Alexander Cegan, et al.
Molecular Pharmaceutics
|
April 17, 2023
Molecular Design of <sup>68</sup>Ga- and <sup>89</sup>Zr-Labeled Anticalin Radioligands for PET-Imaging of PSMA-Positive Tumors
Volker Morath, Corinna Brandt, Friedrich-Christian Deuschle, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 18, 2021
α-Synuclein in Plasma-Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease
Anne Stuendl, Tanja Kraus, Madhurima Chatterjee, et al.
European Journal of Neurology
|
July 1, 2024
Association of elevated cerebrospinal fluid levels of the longevity protein α-Klotho with a delayed onset of cognitive impairment in Parkinson's disease patients
Milan Zimmermann, Madeleine Fandrich, Meike Jakobi, et al.
Plos One
|
November 8, 2012
Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia
Walter Maetzler, Youyong Tian, Stephanie Maria Baur, et al.
Clinical Chemistry and Laboratory Medicine
|
June 29, 2019
Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches
Carlo Wilke, Fani Pujol-Calderón, Christian Barro, et al.
Plos One
|
March 12, 2016
Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors
Felix P Bernhard, Sebastian Heinzel, Gerhard Binder, et al.
Page
of 6